Beta-Blockers
That is:"Beta-blockers, ideally non-selective beta-blockers , are recommended in LQTS patients with documented QT interval prolongation, to reduce risk of arrhythmic event ," and"in all patients with a clinical diagnosis of CPVT ." "If you have a special subtype of long QT called long QT3, and a sodium channel gene, we have a new recommendation for
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more: